Alphadyne Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-73
Closed -$37.4K – 1149
2026
Q2
$36.3K Sell
73
-8,849
-99% -$3.92M ﹤0.01% 836
2026
Q1
$3.98M Buy
+8,922
New +$4.16M 0.07% 335

Other funds holding VRTX

Alphadyne Asset Management's VRTX Position: Q3 2026 in Review

Alphadyne Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 73 shares — an estimated $37.4K sold.

Alphadyne Asset Management first reported a position in VRTX in Q1 2026 and held it in 2 quarters. The position peaked at $3.98M in Q1 2026. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Alphadyne Asset Management reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Alphadyne Asset Management sold 73 Vertex Pharmaceuticals shares in Q3 2026, an estimated $37.4K.
  • Alphadyne Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2026 and held it in 2 quarters.
  • Alphadyne Asset Management's Vertex Pharmaceuticals position peaked at $3.98M in Q1 2026.
  • 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Alphadyne Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.